CH330664A - Process for the preparation of therapeutically valuable aminosalicylic acid derivatives - Google Patents

Process for the preparation of therapeutically valuable aminosalicylic acid derivatives

Info

Publication number
CH330664A
CH330664A CH330664DA CH330664A CH 330664 A CH330664 A CH 330664A CH 330664D A CH330664D A CH 330664DA CH 330664 A CH330664 A CH 330664A
Authority
CH
Switzerland
Prior art keywords
aminosalicylic acid
water
therapeutically valuable
acid derivatives
preparation
Prior art date
Application number
Other languages
German (de)
Inventor
Paul Dr Ochwat
Original Assignee
Cassella Farbwerke Mainkur Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella Farbwerke Mainkur Ag filed Critical Cassella Farbwerke Mainkur Ag
Publication of CH330664A publication Critical patent/CH330664A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Description

  

  
 



  Verfahren zur Herstellung therapeutisch wertvoller   Aminosalicylsäurederivate   
Es wurde gefunden, dass man therapeutisch wertvolle Aminosalieylsäurederivate erhält, wenn man Dichlornaphtochinone, die wasserlöslich machende Gruppen enthalten, mit einer Aminosalicylsäure umsetzt. Als wasserlöslich machende Gruppen kommen dabei z. B. Sulfooder Carboxylgruppen in Betracht. Die erhaltenen Verbindungen zeichnen sich insbesondere durch tuberculostatische Wirkung aus.



   Beispiel
In 450 Teilen destilliertem Wasser werden 33 Teile   2,3- dichlor -1,4 - naphtochinon-5    sulfonsaures Natrium mit 18 Teilen 13 aminosalicylsaurem Natrium bei Zimmertemperatur mehrere Stunden verrührt. Dann wird auf 900 erhitzt und die erhaltene Lösung filtriert.



  Aus dem Filtrat scheidet sich das Kondensationsprodukt beim Erkalten ab. Es wird abfiltriert und mit wenig destilliertem Wasser gewaschen. Zur Reinigung kann es aus destilliertem Wasser umkristallisiert werden. Aus den Filtraten können durch Aussalzen weitere Mengen gewonnen werden.



   Getrocknet stellt das Produkt ein tief dunkelbraunes, in Wasser leicht lösliches Pulver dar.



   Die Reaktion verläuft nach folgender Glei  chung:   
EMI1.1     
 wobei im Endprodukt die Sulfonsäuregruppe die 5- oder 8-Stellung des Naphthalinkernes einnehmen kann.  



   PATENTANSPRUCH
Verfahren zur Herstellung therapeutisch wertvoller Aminosalicylsäurederivate, dadurch gekennzeichnet, dass man   Dichlornaphto-    chinone, die wasserlöslieh machende Gruppen enthalten, mit einer Aminosalicylsäure umsetzt. 

**WARNUNG** Ende DESC Feld konnte Anfang CLMS uberlappen**.



   



  
 



  Process for the preparation of therapeutically valuable aminosalicylic acid derivatives
It has been found that therapeutically valuable aminosalicylic acid derivatives are obtained if dichloronaphthoquinones which contain water-solubilizing groups are reacted with an aminosalicylic acid. As water-solubilizing groups come z. B. sulfo or carboxyl groups. The compounds obtained are distinguished in particular by a tuberculostatic effect.



   example
In 450 parts of distilled water, 33 parts of 2,3-dichloro-1,4-naphthoquinone-5 sulfonic acid sodium are stirred with 18 parts 13 aminosalicylic acid sodium at room temperature for several hours. It is then heated to 900 and the resulting solution is filtered.



  The condensation product separates out of the filtrate on cooling. It is filtered off and washed with a little distilled water. It can be recrystallized from distilled water for cleaning. Further quantities can be obtained from the filtrates by salting out.



   When dried, the product is a deep, dark brown powder that is easily soluble in water.



   The reaction proceeds according to the following equation:
EMI1.1
 where in the end product the sulfonic acid group can occupy the 5- or 8-position of the naphthalene nucleus.



   PATENT CLAIM
Process for the production of therapeutically valuable aminosalicylic acid derivatives, characterized in that dichloronaphthoquinones which contain water-solubilizing groups are reacted with an aminosalicylic acid.

** WARNING ** End of DESC field could overlap beginning of CLMS **.



   

 

Claims (1)

**WARNUNG** Anfang CLMS Feld konnte Ende DESC uberlappen **. ** WARNING ** Beginning of CLMS field could overlap end of DESC **. Verfahren zur Herstellung therapeutisch wertvoller Aminosalicylsäurederivate Es wurde gefunden, dass man therapeutisch wertvolle Aminosalieylsäurederivate erhält, wenn man Dichlornaphtochinone, die wasserlöslich machende Gruppen enthalten, mit einer Aminosalicylsäure umsetzt. Als wasserlöslich machende Gruppen kommen dabei z. B. Sulfooder Carboxylgruppen in Betracht. Die erhaltenen Verbindungen zeichnen sich insbesondere durch tuberculostatische Wirkung aus. Process for the preparation of therapeutically valuable aminosalicylic acid derivatives It has been found that therapeutically valuable aminosalicylic acid derivatives are obtained if dichloronaphthoquinones which contain water-solubilizing groups are reacted with an aminosalicylic acid. As water-solubilizing groups come z. B. sulfo or carboxyl groups. The compounds obtained are distinguished in particular by a tuberculostatic effect. Beispiel In 450 Teilen destilliertem Wasser werden 33 Teile 2,3- dichlor -1,4 - naphtochinon-5 sulfonsaures Natrium mit 18 Teilen 13 aminosalicylsaurem Natrium bei Zimmertemperatur mehrere Stunden verrührt. Dann wird auf 900 erhitzt und die erhaltene Lösung filtriert. example In 450 parts of distilled water, 33 parts of 2,3-dichloro-1,4-naphthoquinone-5 sulfonic acid sodium are stirred with 18 parts 13 aminosalicylic acid sodium at room temperature for several hours. It is then heated to 900 and the resulting solution is filtered. Aus dem Filtrat scheidet sich das Kondensationsprodukt beim Erkalten ab. Es wird abfiltriert und mit wenig destilliertem Wasser gewaschen. Zur Reinigung kann es aus destilliertem Wasser umkristallisiert werden. Aus den Filtraten können durch Aussalzen weitere Mengen gewonnen werden. The condensation product separates out of the filtrate on cooling. It is filtered off and washed with a little distilled water. It can be recrystallized from distilled water for cleaning. Further quantities can be obtained from the filtrates by salting out. Getrocknet stellt das Produkt ein tief dunkelbraunes, in Wasser leicht lösliches Pulver dar. When dried, the product is a deep, dark brown powder that is easily soluble in water. Die Reaktion verläuft nach folgender Glei chung: EMI1.1 wobei im Endprodukt die Sulfonsäuregruppe die 5- oder 8-Stellung des Naphthalinkernes einnehmen kann. The reaction proceeds according to the following equation: EMI1.1 where in the end product the sulfonic acid group can occupy the 5- or 8-position of the naphthalene nucleus. PATENTANSPRUCH Verfahren zur Herstellung therapeutisch wertvoller Aminosalicylsäurederivate, dadurch gekennzeichnet, dass man Dichlornaphto- chinone, die wasserlöslieh machende Gruppen enthalten, mit einer Aminosalicylsäure umsetzt. PATENT CLAIM Process for the preparation of therapeutically valuable aminosalicylic acid derivatives, characterized in that dichloronaphthoquinones containing groups which make water soluble are reacted with an aminosalicylic acid.
CH330664D 1953-04-30 1954-04-28 Process for the preparation of therapeutically valuable aminosalicylic acid derivatives CH330664A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE330664X 1953-04-30

Publications (1)

Publication Number Publication Date
CH330664A true CH330664A (en) 1958-06-15

Family

ID=6191818

Family Applications (1)

Application Number Title Priority Date Filing Date
CH330664D CH330664A (en) 1953-04-30 1954-04-28 Process for the preparation of therapeutically valuable aminosalicylic acid derivatives

Country Status (1)

Country Link
CH (1) CH330664A (en)

Similar Documents

Publication Publication Date Title
CH330664A (en) Process for the preparation of therapeutically valuable aminosalicylic acid derivatives
DE2752287B2 (en) Process for the production of salts of aspartic acid
DE504646C (en) Process for the preparation of anthraquinone and its offshoots
AT218681B (en) Process for the preparation of caffoyl esters of quinic acid
AT216000B (en) Process for the preparation of 6-chloro-7-sulfonamido-1,2,4-benzothiadiazine-1,1-dioxyden
AT311974B (en) Process for the production of new sulfanilamides
AT233010B (en) Process for the preparation of new benzo-dihydro-1, 2, 4-thiadiazine-1, 1-dioxyden
AT368147B (en) METHOD FOR PRODUCING NEW GLYOXYL ACID COMPOUNDS
AT254391B (en) Process for the production of new antibiotic substances of the Cephalosporin C series
AT234681B (en) Process for the preparation of new 1-methyl-1,2-di- [benzimidazolyl- (2 ')] - ethylene compounds
AT214448B (en) Process for the preparation of the new 10- (N-β-hydroxyethyl-piperazinyl-N'-propyl) -2-chloro-phenothiazine-5-oxide
AT220766B (en) Process for the preparation of 3β-acyloxy-Δ <5,16> -pregnadien-20-one
AT230881B (en) Process for the preparation of propionic acid-3,4-dichloroanilide
DE841916C (en) Process for the preparation of oxy compounds of the benzoxanthene series
AT200133B (en) Process for the preparation of new aromatic azonitroso compounds
CH208531A (en) Process for the production of a fluoranthendicarboxylic acid.
DE598477C (en) Process for the preparation of substituted aminopyridines
DE825548C (en) Process for the preparation of new diquartar salts of pyrimidylaminocinnolines
CH349599A (en) Process for the production of new antituberculotics
CH264198A (en) Process for the production of a vat dye.
CH269401A (en) Process for the representation of a basic ether.
CH194997A (en) Process for the preparation of N- (γ-diethylaminopropyl) -5-amino-m-phenanthroline.
CH269409A (en) Process for the representation of a basic ether.
CH278134A (en) Process for the preparation of p-ethyl-ureido-benzalthiosemicarbazone.
CH205525A (en) Process for the production of melamine.